Xinying Li , Ding Zhu , Yanguo Wang, Chuanqi Zhao, Yuangang Lu
{"title":"Formononetin enhances angiogenesis in diabetic wounds by inhibiting ferroptosis through suppression of mtROS-mediated xCT/GPX4 upregulation","authors":"Xinying Li , Ding Zhu , Yanguo Wang, Chuanqi Zhao, Yuangang Lu","doi":"10.1016/j.tice.2025.103141","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Impaired angiogenesis critically contributes to delayed wound healing in diabetic patients. Mitochondrial damage in endothelial cells worsens this vascular dysfunction. Formononetin (FMN), a phytoestrogen from <em>Astragalus</em> roots, is traditionally used to enhance blood function and microcirculation; however, its mechanism remains unclear. This study investigates whether FMN protects human umbilical vein endothelial cells (HUVECs) from high glucose (HG)-induced ferroptosis, and we also evaluated its potential to enhance vascular repair and accelerate diabetic wound healing.</div></div><div><h3>Methods</h3><div>We used Western Blotting to measure ferroptosis markers including the cystine/gluta-mate antiporter system (xCT) and glutathione peroxidase 4 (GPX4) in both HUVECs and diabetic mouse wound tissue. To assess oxidative stress, we measured glutathione content (GSH), malondialdehyde production (MDA), and intracellular iron accumulation. Mitochondrial changes were evaluated through MitoSOX, TOMM20 protein expression, and JC-1 fluorescence. Wound tissue sections were processed for H&E staining to examine healing stages, and CD31 immunofluorescence was performed to visualize angiogenesis in the wound tissue.</div></div><div><h3>Results</h3><div>FMN effectively reduced ferroptosis markers in HG-treated HUVECs, and Erastin treatment abolished this protective effect. The compound appeared to block ferroptosis through two mechanisms: restoration of mitochondrial integrity and reactivation of the xCT/GPX4 antioxidant system. When we tested FMN in diabetic mice, wound closure rates improved substantially, the expression of xCT and GPX4 was increased, and CD31 expression in wound vessels increased, which matched what we observed in vitro.</div></div><div><h3>Conclusion</h3><div>Ferroptosis is critically involved in the pathogenesis of diabetic wounds. FMN exerts protective effects against HG-induced ferroptosis in HUVECs via restoration of mitochondrial function and mitigation of mitochondrial reactive oxygen species (mtROS) accumulation through xCT/GPX4 activation. This evidence suggests FMN could serve as a promising natural therapeutic agent for diabetic wound treatment.</div></div>","PeriodicalId":23201,"journal":{"name":"Tissue & cell","volume":"98 ","pages":"Article 103141"},"PeriodicalIF":2.5000,"publicationDate":"2025-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Tissue & cell","FirstCategoryId":"99","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0040816625004239","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ANATOMY & MORPHOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Impaired angiogenesis critically contributes to delayed wound healing in diabetic patients. Mitochondrial damage in endothelial cells worsens this vascular dysfunction. Formononetin (FMN), a phytoestrogen from Astragalus roots, is traditionally used to enhance blood function and microcirculation; however, its mechanism remains unclear. This study investigates whether FMN protects human umbilical vein endothelial cells (HUVECs) from high glucose (HG)-induced ferroptosis, and we also evaluated its potential to enhance vascular repair and accelerate diabetic wound healing.
Methods
We used Western Blotting to measure ferroptosis markers including the cystine/gluta-mate antiporter system (xCT) and glutathione peroxidase 4 (GPX4) in both HUVECs and diabetic mouse wound tissue. To assess oxidative stress, we measured glutathione content (GSH), malondialdehyde production (MDA), and intracellular iron accumulation. Mitochondrial changes were evaluated through MitoSOX, TOMM20 protein expression, and JC-1 fluorescence. Wound tissue sections were processed for H&E staining to examine healing stages, and CD31 immunofluorescence was performed to visualize angiogenesis in the wound tissue.
Results
FMN effectively reduced ferroptosis markers in HG-treated HUVECs, and Erastin treatment abolished this protective effect. The compound appeared to block ferroptosis through two mechanisms: restoration of mitochondrial integrity and reactivation of the xCT/GPX4 antioxidant system. When we tested FMN in diabetic mice, wound closure rates improved substantially, the expression of xCT and GPX4 was increased, and CD31 expression in wound vessels increased, which matched what we observed in vitro.
Conclusion
Ferroptosis is critically involved in the pathogenesis of diabetic wounds. FMN exerts protective effects against HG-induced ferroptosis in HUVECs via restoration of mitochondrial function and mitigation of mitochondrial reactive oxygen species (mtROS) accumulation through xCT/GPX4 activation. This evidence suggests FMN could serve as a promising natural therapeutic agent for diabetic wound treatment.
期刊介绍:
Tissue and Cell is devoted to original research on the organization of cells, subcellular and extracellular components at all levels, including the grouping and interrelations of cells in tissues and organs. The journal encourages submission of ultrastructural studies that provide novel insights into structure, function and physiology of cells and tissues, in health and disease. Bioengineering and stem cells studies focused on the description of morphological and/or histological data are also welcomed.
Studies investigating the effect of compounds and/or substances on structure of cells and tissues are generally outside the scope of this journal. For consideration, studies should contain a clear rationale on the use of (a) given substance(s), have a compelling morphological and structural focus and present novel incremental findings from previous literature.